AzTrials
AzTrials

Asphyxia NeonatorumNCT00136708

First Breath: Neonatal Resuscitation in Developing Countries

A study testing Neonatal Resuscitation in people with Asphyxia Neonatorum, run by NICHD Global Network for Women's and Children's Health at 7 sites in 6 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In developing countries, neonatal death from birth asphyxia is a major problem. This study will be conducted in several countries to determine if the combined Neonatal Resuscitation Program/Essential Newborn Care Program compared to the new World Health Organization (WHO) basic perinatal care education of health care… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Asphyxia Neonatorum
What is being tested?
Neonatal Resuscitation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120,009 participants
Where
7 sitesin 6 countries
Study dates
Mar 2005to Jun 2008
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Live births with a weight ≥ 1500 grams (community minimum)
  • Infants born in participating communities

Who cannot join

  • Stillbirths
  • Infants with suspected/confirmed lethal malformations (e.g. anencephaly, Trisomy 13 or 18, or cyanotic or left-sided congenital heart disease that will not be repaired)
  • Any infant who is transported/brought to the center after delivery

Trial locations and contacts

7 sites in 6 countries.

7 sites in 6 countries

India2 sites
  • Study site

    Belagavi

  • Study site

    Bhubaneswar, Odisha

Other trials in India

Argentina1 site
  • Study site

    Buenos Aires

Other trials in Argentina

Guatemala1 site
  • Study site

    Guatemala City

Other trials in Guatemala

Pakistan1 site
  • Study site

    Karachi

Other trials in Pakistan

Republic of the Congo1 site
  • Study site

    Kinshasa

Other trials in Republic of the Congo

Zambia1 site
  • Study site

    Lusaka

Other trials in Zambia

About this study

Official title: FIRST BREATH: Neonatal Resuscitation in Developing Countries

In developing countries, neonatal death from birth asphyxia is a major problem. This study will be conducted in several countries to determine if the combined Neonatal Resuscitation Program/Essential Newborn Care Program compared to the new World Health Organization (WHO) basic perinatal care education of health care providers (Essential Newborn Care Program) results in reduced mortality due to perinatal asphyxia.

Read the detailed description

Birth asphyxia (defined as "failure to initiate and sustain breathing at birth") has been identified by the WHO as the most frequent cause of early deaths worldwide, accounting for about 20% of neonatal mortality. Although prompt resuscitation after birth can prevent many of the deaths and reduce disabilities in survivors from birth asphyxia, the WHO has concluded that resuscitation is often not initiated or the methods used are inadequate or wrong. The Neonatal Resuscitation Program (NRP) has been universally accepted in the developed world but has had limited dissemination in many developing countries. The primary hypothesis of this randomized controlled trial is that implementation of the combined Neonatal Resuscitation Program/WHO Essential Newborn Care (ENC) Program, compared to basic neonatal care education of health care providers (ENC only) will result in reduced neonatal 7 day mortality.

The study design will include education and training of personnel at the community level and implementation of an NRP intervention to assure validity, accuracy, and precision of the estimate of the treatment effects. The primary hypothesis is that implementation of the NRP educational programs will result in a decrease in neonatal mortality. The primary outcome will be a decrease in all cause early (7 day) neonatal mortality, mortality due to any cause, in the NRP trained communities when compared to the non-NRP trained communities. Secondary outcomes will include early (7 day) neonatal mortality associated with perinatal asphyxia, mortality or hypoxic ischemic encephalopathy (HIE) at 7 days, need for advanced resuscitation, and Apgar scores at 5 minutes as well as providers' self-efficacy, knowledge, competence, and performance in neonatal resuscitation.

This cluster randomized trial will be performed in communities of the Global Network (GN) sites. One half of the communities will be randomized to Early Training and Intervention with NRP; the other half will be randomized to Late Training and Intervention. Data collection will be obtained at baseline for both groups in order to establish baseline data including neonatal mortality and asphyxia. Following the baseline data collection period, training of the health care providers with the WHO Integrated Management of Pregnancy and Childbirth: Pregnancy, Postpartum, and Newborn Care Guide for Essential Practice (2003): Essential Newborn Care Program (ENC) will be performed using a train-the-trainer system. Following this training, communities will be randomized to Early or Late Training and Intervention with ENC. Initially, the Early Training and Intervention sites will have a program of train-the-trainers in NRP. Following a 12-month period of intervention (NRP vs. control), the providers of the Late Training and Intervention sites will have training in NRP.

Based on the early (first 7 days after birth) neonatal mortality data collected in preparation for this protocol, we estimate that there are 25 neonatal deaths/1000 live births. The trial is designed to identify a relative risk reduction of at least 20% (absolute risk reduction of 5% or 5/1000 live births, from 25/1000 to 20/1000 live births) in the treatment group as compared to the control group. The sample size necessary for the 20% relative risk reduction will be at least 32 communities with an average number of births of >500 per year; however, we plan to randomize at least 40 communities to account for potential drop-out. The proposed enrollment period for the randomized intervention will last one year.

Being tested
Neonatal Resuscitation
Keywords
Global Network, Neonatal mortality, Asphyxia, Maternal and child health, International, Zambia, Pakistan, India, Democratic Republic of Congo, Uruguay, Guatemala, Argentina, Neonatal resuscitation
Medical subject headings
Asphyxia Neonatorum, Asphyxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neonatal ResuscitationProcedure or surgery

Study groups in NCT00136708
Study groupRoleWhat they receive
NRP Training (Intervention)ExperimentalTraining in AAP neonatal resuscitation training program
Receives: Procedure: Neonatal Resuscitation
ControlOtherNot described
Receives: Procedure: Neonatal Resuscitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neonatal mortality

    Measured: 7 days

Secondary outcomes (7)
  1. Neonatal mortality due to perinatal asphyxia

    Measured: 7 days

  2. Hypoxic ischemic encephalopathy

    Measured: 7 days

  3. Need for advanced resuscitation

    Measured: 7 days

  4. Apgar score at 5 minutes

    Measured: 5 minutes

  5. Perinatal mortality at 7 days

    Measured: 7 days

  6. Stillbirth or neonatal mortality

    Measured: 7 days

  7. Stillbirth and/or neonatal mortality at 28 days

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2005 (estimated)
  2. Study startMar 2005
  3. Primary completionJun 2008
  4. Study completionJun 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120,009 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00136708
Sponsor's protocol ID
CP02 FIRST BREATH
Status last verified
Jul 2014
First submitted
25 Aug 2005
Last updated
31 Jul 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Matendo R, Engmann C, Ditekemena J, Gado J, Tshefu A, Kinoshita R, McClure EM, Moore J, Wallace D, Carlo WA, Wright LL, Bose C. Reduced perinatal mortality following enhanced training of birth attendants in the Democratic Republic of Congo: a time-dependent effect. BMC Med. 2011 Aug 4;9:93. doi: 10.1186/1741-7015-9-93.

    PubMed 21816050
  • Carlo WA, Goudar SS, Jehan I, Chomba E, Tshefu A, Garces A, Parida S, Althabe F, McClure EM, Derman RJ, Goldenberg RL, Bose C, Hambidge M, Panigrahi P, Buekens P, Chakraborty H, Hartwell TD, Moore J, Wright LL; First Breath Study Group. High mortality rates for very low birth weight infants in developing countries despite training. Pediatrics. 2010 Nov;126(5):e1072-80. doi: 10.1542/peds.2010-1183. Epub 2010 Oct 11.

    PubMed 20937655
  • Carlo WA, Goudar SS, Jehan I, Chomba E, Tshefu A, Garces A, Parida S, Althabe F, McClure EM, Derman RJ, Goldenberg RL, Bose C, Krebs NF, Panigrahi P, Buekens P, Chakraborty H, Hartwell TD, Wright LL; First Breath Study Group. Newborn-care training and perinatal mortality in developing countries. N Engl J Med. 2010 Feb 18;362(7):614-23. doi: 10.1056/NEJMsa0806033.

    PubMed 20164485

Questions about this trial

What is this clinical trial studying?

A study testing Neonatal Resuscitation in people with Asphyxia Neonatorum, run by NICHD Global Network for Women's and Children's Health at 7 sites in 6 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in India, Argentina, Guatemala, Pakistan, Republic of the Congo and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neonatal mortality (time frame: 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00136708, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in